Gold-Silver Project Moves Into Critical Test Phase as 2027 Resource Target Takes Shape
The Next Move in Junior Miners May Be Closer Than It Appears
Contributed Opinion
Permits Filed, Drilling Targeted for May as 70 km Survey and Mill Build Advance in Tandem
Tesla Is Creating Multiple Emerging Businesses Simultaneously
Contributed Opinion
Mining Co's. Target Massive Arabian-Nubian Shield Gold Opportunities in Egypt
Exploration Company Uncovers High-Grade Gold in Ontario Breakthrough
Third Drill Rig Targets Undrilled Porphyry Zones as District-Scale Copper System Expands
Tungsten Explorer Confirms New Breccia; Drilling Massive 200m of Mineralization in Portugal
Allied Critical Metals Inc. (ACM:CSE; ACMIF:OTCQB; 0VJ0:FSE) announces results from its Borralha Tungsten Project as military demand for the metal tightens.Lithium Developer Lands Spot in US-Japan Critical Minerals Partnership
Atlas Lithium Corp.'s (ATLX:NASDAQ) Neves Project in Brazil is being considered for financial backing by Japan and the U.S. governments.Lucky Strike Zone Poised to Exceed Sullivan, Water Rights Secured
Research Report
P2 Gold Inc. (PGLD:TSXV) is expanding Lucky Strike drilling results and a key water rights acquisition that de-risks the Gabbs Project ahead of Q4-2026 feasibility, noted a Couloir Capital report. Canadian Biotech Co. Appoints Elite Regulatory Expert for Chile Expansion
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) appoints Chilean policy leader Felipe Leyton for the mining rollout of its AI impairment detection tech.British Columbia Exploration Co. Expands Significant Copper-Gold Footprint
Amarc Resources Ltd. (AHR:TSX.V; AXREF.OB:OTCBB) advances large-scale copper-gold discovery, backed by a CA$30M investment and expanding porphyry system potential.High-Grade Gold Hits and Expansion Drilling Drive Momentum at Northwestern Ontario Project
West Red Lake Gold Mines Ltd. (WRLG:TSX.V; WRLGF:OTCQX; UJO:FSE) reported new high-grade drill results from its recently completed 6,300-meter program at the Rowan Project.California Biotech Co. Advances Depression Drug Breakthrough
Alto Neuroscience Inc. (ANRO:NYSE) pivots after mixed trial results, targeting treatment-resistant depression with analyst support and major market growth potential.Stagflation Not Seen in Decades
Contributed Opinion
Tavi Costa of Azuria Capital shares his thoughts on the impending stagflation and one mining company he believes is worth looking into. San Francisco Pharma Co.'s HORIZON Phase 2 Data Validates APOL1 Path to Pivotal Trial
Research Report
H.C. Wainwright reiterated its rating and price target on Maze Therapeutics (MAZE:NASDAQ), following KOL calls that validated the HORIZON Phase 2 dataset as biologically coherent, confirmed the diabetic cohort signal as drug-attributable proof of concept, and outlined a clear path to pivotal trials. 
Streetwise Key Charts
